Ibuprofen, azithromycin: How unlicensed East Delhi pharmacy was busted selling medicines

This incident highlights a significant gap in regulatory enforcement and compliance within the pharmaceutical sector. The primary legislation governing this area is the Drugs and Cosmetics Act, 1940, which regulates the import, manufacture, and distribution of drugs in India. The fact that a pharmacy continued to operate and sell restricted medicines like antibiotics (such as amoxicillin and azithromycin) without a valid license, and even after cancellation, points to inadequate post-cancellation surveillance. The State Drugs Standard Control Organisation (SDSCO) is responsible for licensing and monitoring retail pharmacies, but resource constraints and corruption often hinder effective oversight. From a UPSC governance perspective, this raises questions about the efficacy of regulatory bodies, the need for robust digital tracking systems for licenses, and the necessity of stricter penalties to deter such violations. The ease with which decoy customers purchased prescription drugs without a memo also indicates a lack of adherence to standard operating procedures meant to prevent the misuse of medications.

The unmonitored sale of antibiotics like azithromycin and ciprofloxacin poses a severe threat to public health, primarily contributing to the global crisis of Antimicrobial Resistance (AMR). AMR occurs when bacteria evolve to resist the drugs designed to kill them, often driven by the overuse and misuse of antibiotics. The World Health Organization considers AMR one of the top ten global public health threats. In India, self-medication and over-the-counter availability of antibiotics without a prescription (a violation of Schedule H and H1 of the Drugs and Cosmetics Rules, 1945) exacerbate this problem. The seizure of expired medicines also highlights the risk of adverse drug reactions or ineffective treatments. UPSC aspirants should connect this localized incident to the broader national health policy challenges, emphasizing the need for strict enforcement of prescription rules, public awareness campaigns against self-medication, and strengthening the healthcare infrastructure to ensure safe access to medicines.

The regulation of drugs falls under the Concurrent List (List III) of the Seventh Schedule of the Constitution of India. This means both the Central and State governments have the power to legislate on matters related to drugs and poisons. While the Central government, through the Central Drugs Standard Control Organisation (CDSCO), handles the approval of new drugs, clinical trials, and setting standards, the State governments are responsible for the licensing of manufacturing and sales premises. This dual regulatory structure often leads to coordination challenges and inconsistencies in enforcement across different states. The Delhi incident illustrates the critical role of state-level enforcement agencies (like the Delhi Drugs Control Department) in implementing national standards. A potential UPSC mains question could analyze the effectiveness of this federal structure in drug regulation and suggest reforms, such as centralizing certain licensing functions or creating a more unified regulatory framework to prevent such illegal operations.